NO803916L - Fremgangsmaate ved fremstilling av en terapeutisk virksom blanding - Google Patents

Fremgangsmaate ved fremstilling av en terapeutisk virksom blanding

Info

Publication number
NO803916L
NO803916L NO803916A NO803916A NO803916L NO 803916 L NO803916 L NO 803916L NO 803916 A NO803916 A NO 803916A NO 803916 A NO803916 A NO 803916A NO 803916 L NO803916 L NO 803916L
Authority
NO
Norway
Prior art keywords
preparing
procedure
animals
ester
therapeutic active
Prior art date
Application number
NO803916A
Other languages
English (en)
Norwegian (no)
Inventor
Giancarlo Sportoletti
Alessandro Baglioni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of NO803916L publication Critical patent/NO803916L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO803916A 1979-12-28 1980-12-23 Fremgangsmaate ved fremstilling av en terapeutisk virksom blanding NO803916L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28417/79A IT1127322B (it) 1979-12-28 1979-12-28 Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici

Publications (1)

Publication Number Publication Date
NO803916L true NO803916L (no) 1981-06-29

Family

ID=11223560

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803916A NO803916L (no) 1979-12-28 1980-12-23 Fremgangsmaate ved fremstilling av en terapeutisk virksom blanding

Country Status (24)

Country Link
US (1) US4282217A (forum.php)
JP (1) JPS56103113A (forum.php)
AR (1) AR224288A1 (forum.php)
AU (1) AU524820B2 (forum.php)
BE (1) BE886758A (forum.php)
BR (1) BR8008493A (forum.php)
CA (1) CA1161362A (forum.php)
DE (1) DE3027039C2 (forum.php)
DK (1) DK524080A (forum.php)
ES (1) ES8205417A1 (forum.php)
FI (1) FI803767L (forum.php)
FR (1) FR2472388A1 (forum.php)
GB (1) GB2066072B (forum.php)
GR (1) GR72504B (forum.php)
IE (1) IE50549B1 (forum.php)
IN (1) IN152354B (forum.php)
IT (1) IT1127322B (forum.php)
LU (1) LU83029A1 (forum.php)
NL (1) NL182775C (forum.php)
NO (1) NO803916L (forum.php)
PH (1) PH17384A (forum.php)
PT (1) PT72274B (forum.php)
SE (1) SE8009103L (forum.php)
ZA (1) ZA807516B (forum.php)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
JPS6310084U (forum.php) * 1986-07-07 1988-01-22
US5059712A (en) * 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body
US5216025A (en) * 1989-09-13 1993-06-01 Board Of Regents, The University Of Texas System Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5312835A (en) * 1989-09-13 1994-05-17 Board Of Regents, The University Of Texas System Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension
US5158883A (en) * 1989-09-13 1992-10-27 Cornell Research Foundation, Inc. Method of using aminoarginine to block nitric oxide formation in vitro
US5770623A (en) * 1989-09-13 1998-06-23 Board Of Regents, The University Of Texas System Argine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
US5196195A (en) * 1990-03-27 1993-03-23 Cornell Research Foundation, Inc. Use of arginase to control nitric oxide formation
US5395612A (en) * 1990-03-27 1995-03-07 Cornell Research Foundation, Inc. Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an α1 adrenergic agonist
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
US5273875A (en) * 1991-03-22 1993-12-28 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
US5132453A (en) * 1991-03-22 1992-07-21 Cornell Research Foundation, Inc. N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
JP2534423B2 (ja) 1991-12-26 1996-09-18 コーネル・リサーチ・ファンデーション・インコーポレイテッド 酸化窒素の過剰生産から生じる血管失調を阻止する阻害剤
US5877176A (en) * 1991-12-26 1999-03-02 Cornell Research Foundation, Inc. Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US20020031513A1 (en) * 1997-11-24 2002-03-14 Shamir Leibovitz Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
KR100472303B1 (ko) * 2002-05-21 2005-03-08 김영미 결장표적성 프로드럭으로서의 코티코스테로이드21-설페이트 소듐 유도체
US8439922B1 (en) 2008-02-06 2013-05-14 NiVasive, Inc. Systems and methods for holding and implanting bone anchors
US9198698B1 (en) 2011-02-10 2015-12-01 Nuvasive, Inc. Minimally invasive spinal fixation system and related methods
US9486256B1 (en) 2013-03-15 2016-11-08 Nuvasive, Inc. Rod reduction assemblies and related methods
US9974577B1 (en) 2015-05-21 2018-05-22 Nuvasive, Inc. Methods and instruments for performing leveraged reduction during single position spine surgery
US10398481B2 (en) 2016-10-03 2019-09-03 Nuvasive, Inc. Spinal fixation system
US11051861B2 (en) 2018-06-13 2021-07-06 Nuvasive, Inc. Rod reduction assemblies and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320125A (en) * 1964-04-28 1967-05-16 Merck & Co Inc Inhalation aerosol composition
CA939265A (en) * 1967-11-18 1974-01-01 Yoshitaka Ikezuki Injectable compositions for alleviating the pain incurred from administrations of injections
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
JPS5035061A (forum.php) * 1973-07-28 1975-04-03

Also Published As

Publication number Publication date
FI803767A7 (fi) 1981-06-29
PT72274B (en) 1981-11-05
LU83029A1 (de) 1981-03-27
DK524080A (da) 1981-06-29
JPS56103113A (en) 1981-08-18
JPS6144844B2 (forum.php) 1986-10-04
BR8008493A (pt) 1981-07-14
NL182775B (nl) 1987-12-16
US4282217A (en) 1981-08-04
BE886758A (nl) 1981-04-16
AR224288A1 (es) 1981-11-13
DE3027039A1 (de) 1981-07-02
GB2066072B (en) 1984-02-01
FR2472388A1 (fr) 1981-07-03
IE50549B1 (en) 1986-05-14
IT1127322B (it) 1986-05-21
IT7928417A0 (it) 1979-12-28
CA1161362A (en) 1984-01-31
IE802605L (en) 1981-06-28
GR72504B (forum.php) 1983-11-15
ES497508A0 (es) 1982-06-16
FR2472388B1 (forum.php) 1983-04-01
PH17384A (en) 1984-08-06
DE3027039C2 (de) 1984-05-17
AU6502980A (en) 1981-07-02
NL8006707A (nl) 1981-07-16
ES8205417A1 (es) 1982-06-16
GB2066072A (en) 1981-07-08
IN152354B (forum.php) 1983-12-24
SE8009103L (sv) 1981-06-29
PT72274A (en) 1981-01-01
AU524820B2 (en) 1982-10-07
ZA807516B (en) 1981-11-25
NL182775C (nl) 1988-05-16
FI803767L (fi) 1981-06-29

Similar Documents

Publication Publication Date Title
NO803916L (no) Fremgangsmaate ved fremstilling av en terapeutisk virksom blanding
Kuroda et al. Mechanism for elevation of hepatic cholesterol synthesis and serum cholesterol levels in Triton WR-1339-induced hyperlipidemia
LU85594A1 (de) Oligodeoxynucleotide und polydeoxynucleotide,die mit einem bereich einer bei der virusvermehrung synthetisierten mrna hybridisieren und ihre anwendung als therapeutische wirkstoffe
Thomson et al. Inhibition of immediate hypersensitivity reactions by disodium cromoglycate. Requirements for activity in two laboratory models
RO108220B1 (ro) Preparate farmaceutice,pentru combaterea carceilor musculari si procedeu de obtinere a acestora
Gitlin et al. Site of catabolism of serum albumin
NO170114B (no) Elektrisk kontaktklemme
WO1997038693A1 (en) Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
Banik et al. Effect of Steroidal Anti-Progestins on Implantation of Fertilized Eggs of Rats and Mice.
Broome et al. A new drug for the treatment of fascioliasis in sheep and cattle
Okamoto Influence of L-thyroxine on kynurenine 3-hydroxylase, monoamine oxidase, and rotenone-insensitive NADH-cytochrome C reductase in mitochondrial outer membrane
JPH0778021B2 (ja) 下痢症ウイルス感染阻害剤
NO803918L (no) Fremgangsmaate ved fremstilling av nye estere av arginin
DE69716914T2 (de) Behandlung und prophylaxe von unerwünschten effekten reaktiver sauerstoffverbindungen
Jones et al. Antifertility and dominant lethal mutation studies in male rats with dl-α-chlorohydrin and an amino-analogue
JPH03294230A (ja) 子宮内膜症治療剤
Collins et al. Studies in rhodopsin. 7. Regeneration of rhodopsin by comminuted ox retina
US5854287A (en) D-Propranolol metabolites useful for antioxidant activities
Margolis et al. Cure of Experimental Canine Blacktongue with Optimal and Minimal Doses of Nicotinic Acid: Three Figures
US3175943A (en) Process for stimulating choleresis
WO1990003172A2 (en) Bile acids for treatment of viral infections
Starr et al. Further evidence for the involvement of kinin in anaphylactic shock in the rat
Falcone et al. Cardiotoxicity of doxorubicin: effects of 21-aminosteroids
CN107652265B (zh) 1-(哌啶-4-基)-2-苯并咪唑酮类化合物及其应用
JPS5970615A (ja) 口唇疱疹治療へのウンデシレン酸の使用